comparemela.com

Latest Breaking News On - Dermatological products - Page 1 : comparemela.com

Biofrontera Inc Names Gerard DiGirolamo as National Sales

WOBURN, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of.

United statesMark baldygaGerard digirolamo as national sales directorRutgers universityBiofrontera incPrior to verrica pharmaceuticalsSales at verrica pharmaceuticalsGerard digirolamoNational salesVice presidentVerrica pharmaceuticalsErica monacoChief executive officerField vice presidentExecutive national account managerDistrict sales manager

Biofrontera Inc s Leslie Hopkins Named PM360 Trailblazer

WOBURN, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of.

United statesLeslie hopkinsKayla walshGotham hallAnna stashowerWebsite online initiative of the yearInfectious disease vaccine developmentBiofrontera incWomen healthMen healthAssociate directorTrailblazer brand championElevate healthcareOnline initiativeErica monacoChief executive officer

Global Medicated Skin Care Products Market to Reach US$7 7

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. .

New yorkUnited statesVivier pharmaAge groupGlaxosmithkline plcShiseido co ltdSkin health incPrairie groupLabor force in select countriesKao corporationSkinmedica incHimalaya drug companyEpisciences incOtsuka pharmaceutical co ltdStiefel laboratories incMedimetriks pharmaceuticals inc

Biofrontera Inc Appoints Kevin D Weber to its Board of

WOBURN, Mass., March 07, 2022 (GLOBE NEWSWIRE) Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the.

United statesKevind weberTirtht patelMichigan universityBiofrontera incBoard of biofrontera incMedicis pharmaceuticalsParaffin internationalArizona bioindustry associationBusiness administrationPharmaceuticals incAmerican chronic pain associationHyperion therapeuticsExecutive chairmanAmerican academyPain medicine foundation

Biofrontera Inc to Present at the 34th Annual Roth

WOBURN, Mass., March 09, 2022 (GLOBE NEWSWIRE) Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the.

Laguna niguelUnited statesTirtht patelBlockchain cryptocurrencyOil gas meals miningBusiness servicesTechnology mediaConsumer health wellnessBiofrontera incErica monacoChief executive officerAnnual roth conferenceAnnual rothNasdaq bfriBiofrontera incNasdaq bfri

vimarsana © 2020. All Rights Reserved.